Welcome to our dedicated page for Mrc Global SEC filings (Ticker: MRC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sorting through MRC Global’s inventory accounting notes, backlog disclosures, and covenant tests can feel like inspecting miles of industrial pipe without a map. That complexity is why questions such as “MRC Global SEC filings explained simply” and “How do I track MRC Global insider trading Form 4 transactions?” surface every quarter.
Stock Titan answers by pairing real-time EDGAR feeds with AI-powered summaries that translate legal jargon into clear insights. Need the latest MRC Global quarterly earnings report 10-Q filing? It lands here seconds after submission, already tagged with ratio analysis and segment commentary. Curious about procurement executives buying stock? Our dashboard flags MRC Global Form 4 insider transactions real-time, turning raw data into trend lines. Even the 300-page MRC Global annual report 10-K simplified is condensed so you see inventory turns, energy-cycle sensitivity, and valve automation backlog first.
Every disclosure type is covered: the MRC Global proxy statement executive compensation reveals how management bonuses link to working-capital targets; MRC Global 8-K material events explained highlights sudden project awards or covenant amendments; and our AI offers scenario checklists for understanding MRC Global SEC documents with AI. Practical use cases abound—monitor “MRC Global earnings report filing analysis” before calls, download risk-factor redlines, or receive alerts on “MRC Global executive stock transactions Form 4” when leadership acts. With comprehensive coverage and expert context, you’ll spend minutes, not hours, extracting decisions from MRC Global’s filings.
MRC Global (NYSE:MRC) entered into a definitive all-stock merger agreement with DNOW on 26 June 2025. Each MRC share will convert into 0.9489 DNOW shares, after a two-step merger that will leave MRC as a wholly-owned DNOW subsidiary.
Closing requires both companies’ shareholder approvals, HSR and other antitrust clearances, effectiveness of a DNOW Form S-4 and NYSE listing of the new DNOW shares. Either party may terminate after 26 June 2026 (extendable twice to 26 Dec 2026); break-up fees are $45.5 million plus expense reimbursement up to $8.5 million.
DNOW’s post-deal board will have ten directors, including two from MRC. MRC also extended non-compete periods for three named executives and awarded CFO John P. McCarthy a $150 k retention bonus.